Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China
· Delayed Price · Currency is CNY 19.83
+0.63 (3.28%)
Apr 29, 2026, 3:13 PM CST
SHE:300497 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 10,681 | 8,139 | 4,492 | 5,042 | 7,110 | 8,887 | Upgrade
|
| Market Cap Growth | 135.23% | 81.17% | -10.90% | -29.09% | -19.99% | 34.93% | Upgrade
|
| Enterprise Value | 11,848 | 9,245 | 5,432 | 5,887 | 7,337 | 8,195 | Upgrade
|
| Last Close Price | 19.83 | 15.11 | 8.34 | 9.36 | 13.20 | 16.33 | Upgrade
|
| PE Ratio | 2717.12 | - | - | - | - | 181.99 | Upgrade
|
| Forward PE | 15.37 | 29.64 | 29.64 | 29.64 | 29.64 | 19.92 | Upgrade
|
| PS Ratio | 8.16 | 6.87 | 3.81 | 3.13 | 4.32 | 6.22 | Upgrade
|
| PB Ratio | 4.71 | 3.70 | 2.06 | 2.04 | 2.64 | 3.05 | Upgrade
|
| P/TBV Ratio | 5.45 | 4.29 | 2.31 | 2.25 | 2.93 | 3.39 | Upgrade
|
| P/FCF Ratio | - | - | 97.89 | - | - | - | Upgrade
|
| P/OCF Ratio | 250.18 | 129.86 | 23.94 | - | - | 122.88 | Upgrade
|
| EV/Sales Ratio | 9.05 | 7.80 | 4.61 | 3.66 | 4.45 | 5.73 | Upgrade
|
| EV/EBITDA Ratio | 44.18 | 47.14 | - | - | 113.16 | 30.17 | Upgrade
|
| EV/EBIT Ratio | 155.10 | 1079.19 | - | - | - | 47.35 | Upgrade
|
| EV/FCF Ratio | -111.06 | - | 118.36 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.71 | 0.75 | 0.74 | 0.66 | 0.53 | 0.34 | Upgrade
|
| Debt / EBITDA Ratio | 6.03 | 8.42 | - | - | 21.87 | 3.69 | Upgrade
|
| Debt / FCF Ratio | - | - | 34.97 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.50 | 0.53 | 0.42 | 0.36 | 0.14 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.27 | 5.95 | -48.55 | -83.97 | 6.02 | -1.55 | Upgrade
|
| Net Debt / FCF Ratio | -10.72 | -7.19 | 19.77 | -2.92 | -0.67 | 0.69 | Upgrade
|
| Asset Turnover | 0.29 | 0.27 | 0.25 | 0.33 | 0.34 | 0.33 | Upgrade
|
| Inventory Turnover | 2.44 | 2.46 | 2.63 | 2.98 | 2.96 | 2.83 | Upgrade
|
| Quick Ratio | 0.88 | 0.82 | 0.81 | 1.11 | 1.32 | 1.38 | Upgrade
|
| Current Ratio | 1.22 | 1.15 | 1.09 | 1.46 | 1.77 | 1.70 | Upgrade
|
| Return on Equity (ROE) | -0.18% | -2.88% | -12.07% | -8.65% | -5.86% | 1.33% | Upgrade
|
| Return on Assets (ROA) | 1.06% | 0.12% | -2.53% | -2.15% | -0.76% | 2.48% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.25% | 0.27% | -5.87% | -5.28% | -2.12% | 5.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.40% | 0.30% | -6.30% | -4.80% | -1.60% | 5.20% | Upgrade
|
| Earnings Yield | 0.04% | -0.68% | -6.06% | -3.98% | -1.99% | 0.55% | Upgrade
|
| FCF Yield | -1.00% | -1.99% | 1.02% | -6.09% | -8.16% | -6.83% | Upgrade
|
| Payout Ratio | 1386.35% | - | - | - | - | 285.02% | Upgrade
|
| Buyback Yield / Dilution | 1.19% | -3.14% | 1.69% | 0.26% | -0.29% | -17.25% | Upgrade
|
| Total Shareholder Return | 1.19% | -3.14% | 1.69% | 0.26% | -0.29% | -17.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.